Active Studies for Enrollment
Explore the latest clinical trials available for enrollment at our institute.
1. Study Name: BHV 3000-406 (C4951004)
Brief Description: A Phase 4, Randomized, Double-blind Placebo-Controlled Trial evaluating the efficacy of a treatment for migraines.
Eligibility Criteria: Adults aged 18 – 65 years.
Duration: 24 weeks.
Contact Information: info@dfccresearch.com
2. Study Name: BHV 3000-407 (C4951012)
Brief Description: A Phase 4, Randomized, Double-blind, Placebo-Controlled Trial assessing a treatment for migraines.
Eligibility Criteria: Adults aged 18 – 65 years.
Duration: 30 weeks.
Contact Information: info@dfccresearch.com
3. Study Name: TAK-279-CD-2001
Brief Description: A Phase 2b, Multicenter, Randomized, Double-Blind Study for Chron’s Disease.
Eligibility Criteria: Adults aged ≥18 and ≤75 years.
Duration: 60 weeks.
Contact Information: info@dfccresearch.com
4. Study Name: TAK-279-UC-2001
Brief Description: A Phase 2, Multicenter, Randomized, Placebo-Controlled Study for Ulcerative Colitis.
Eligibility Criteria: Adults aged ≥18 and ≤75 years.
Duration: 60 weeks.
Contact Information: info@dfccresearch.com
5. Study Name: BIO89-100-231
Brief Description: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study for Hypertriglyceridemia.
Eligibility Criteria: Adults aged ≥22 years.
Duration: 74 weeks.
Contact Information: info@dfccresearch.com
Downloadable Summary
Ready to Take the Next Step?
If you’re interested in advancing medical science and being part of groundbreaking research, we invite you to participate in our clinical trials. Your involvement can make a difference—not just for you, but for countless others in the future.
Contact us today to learn more about our current studies, eligibility criteria, and how you can contribute to the future of healthcare.
📞 Call Us: 516-420-4200
📧 Email Us: info@dfccresearch.com
🌐 Visit Us: Learn More About Our Trials